Skip to main content
SpringerLink
Log in

Präventionsmedizin

Spezieller Impfplan für HIV-Patienten

Vaccines for people living with HIV/AIDS

  • FORTBILDUNG . ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Menschen mit HIV-Infektion sind besonders gefährdet, sich eine Infektionskrankheit zuzuziehen. Ihr Impfschutz sollte deshalb stets umfassend und aktuell sein. Für den Arzt heißt es Aufpassen, da er zum Teil deutlich von den gewohnten STIKO-Empfehlungen abweichen muss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Tab. 2

Literatur

  1. Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut - 2016/2017. Epid Bull 2016;34:301-338

  2. European AIDS Clinical Society. Guidelines - Version 8.1. Verfügbar unter http://www.eacsociety.org/files/guidelines_8.1-english.pdf. 2016

  3. British HIV Association. Guidelines on the use of vaccines in HIV-positive adults. Verfügbar unter http://www.bhiva.org/documents/Guidelines/Vaccination/2015-Vaccination-Guidelines.pdf. 2015

  4. U.S. Department of Health and Human Services, Health Resources and Services Administration. Guide for HIV/AIDS Clinical Care — 2014 Edition. Rockville, MD: U.S. Department of Health and Human Services, 2014

  5. Centers for Disease Control and Prevention. HIV Infection and Adult Vaccination. Verfügbar unter https://www.cdc.gov/vaccines/adults/rec-vac/health-conditions/hiv.html. 2014

  6. World Health Organization. Reported estimates of DTP4 coverage. Verfügbar unter http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragedtp4.html. 2016

  7. World Health Organization. Third dose of polio vaccine. Verfügbar unter http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragepol3.html. 2016

  8. Mullaert J, Abgrall S, Lele N, et al. Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study. Vaccine 2015;33:4938–44

    Article  PubMed  Google Scholar 

  9. Grabmeier-Pfistershammer K, Herkner H, Touzeau-Roemer V, Rieger A, Burgmann H and Poeppl W. Low tetanus, diphtheria and acellular pertussis (Tdap) vaccination coverage among HIV infected individuals in Austria. Vaccine 2015;33:3929–32

    Article  CAS  PubMed  Google Scholar 

  10. Schwarze-Zander C, Draenert R, Lehmann C, et al. Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany. Epidemiol Infect 2017;145:236–244

    Article  CAS  PubMed  Google Scholar 

  11. Dietrich A, Schelling J and Seybold U. [HPV-vaccination - not just for girls]. MMW Fortschr Med 2015;157:47–9

    Article  PubMed  Google Scholar 

  12. Esser S, Kreuter A, Oette M, et al. Deutsch-Österreichische Leitlinie Anale Dysplasien und Analkarzinome bei HIV-Infizierten: Prävention, Diagnostik, Therapie. J Dtsch Dermatol Ges 2015;13:1302–19

    Article  PubMed  Google Scholar 

  13. Frenck RW, Jr., Fiquet A, Gurtman A, et al. Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older. Vaccine 2016;34:3454–62

    Article  CAS  PubMed  Google Scholar 

  14. Jackson LA, Gurtman A, van Cleeff M, et al. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older. Vaccine 2013;31:3594–602

    Article  CAS  PubMed  Google Scholar 

  15. Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2015. Verfügbar unter http://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2015.pdf. 2016

  16. Marcus U, Vogel U, Schubert A, et al. A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, October 2012 to May 2013. Euro Surveill 2013;18

  17. Miller L, Arakaki L, Ramautar A, et al. Elevated risk for invasive meningococcal disease among persons with HIV. Ann Intern Med 2014;160:30–7

    Article  PubMed  Google Scholar 

  18. MacNeil JR, Rubin LG, Patton M, Ortega-Sanchez IR and Martin SW. Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons - Advisory Committee on Immunization Practices, 2016. MMWR Morb Mortal Wkly Rep 2016;65:1189–1194

    Article  PubMed  Google Scholar 

  19. Sonmez E, Sonmez AS, Bayindir Y, Coskun D and Ariturk S. Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals. Vaccine 2002;21:243–6

    Article  CAS  PubMed  Google Scholar 

  20. Robert Koch-Institut. Bericht zur Epidemiologie der Influenza in Deutschland Saison 2014/15. Verfügbar unter https://influenza.rki.de/Saisonberichte/2014.pdf. 2015

  21. Robert Koch-Institut. Bericht zur Epidemiologie der Influenza in Deutschland Saison 2015/16. Verfügbar unter https://influenza.rki.de/Saisonberichte/2015.pdf. 2016

  22. World Health Organization. Vaccines against influenza, WHO position paper — November 2012. Weekly epidemiological record 2012;87:461–476

    Google Scholar 

  23. Jackson BR, Iqbal S, Mahon B, Centers for Disease C and Prevention. Updated recommendations for the use of typhoid vaccine—Advisory Committee on Immunization Practices, United States, 2015. MMWR Morb Mortal Wkly Rep 2015;64:305–8

    PubMed  Google Scholar 

  24. Banda R, Yambayamba V, Lalusha BD, Sinkala E, Kapulu MC and Kelly P. Safety of live, attenuated oral vaccines in HIV-infected Zambian adults: oral vaccines in HIV. Vaccine 2012;30:5656–60

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sektion Klinische Infektiologie, Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Pettenkoferstr. 8a, D-80336, München, Deutschland

    Ulrich Seybold MSc

Authors
  1. Ulrich Seybold MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich Seybold MSc.

Additional information

This article is part of a supplement not sponsored by the industry.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seybold, U. Spezieller Impfplan für HIV-Patienten. MMW - Fortschritte der Medizin 159 (Suppl 2), 23–27 (2017). https://doi.org/10.1007/s15006-017-9730-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-017-9730-2

Keywords

Search

Navigation